4-methylthioamphetamine has been researched along with fluoxetine in 2 studies
| Studies (4-methylthioamphetamine) | Trials (4-methylthioamphetamine) | Recent Studies (post-2010) (4-methylthioamphetamine) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
|---|---|---|---|---|---|
| 38 | 0 | 9 | 10,100 | 1,663 | 3,263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD | 1 |
| Guiry, PJ; Keenan, AK; McBean, GJ; Quinn, ST; Schwab, T | 1 |
2 other study(ies) available for 4-methylthioamphetamine and fluoxetine
| Article | Year |
|---|---|
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1996 |
Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Aorta, Thoracic; Biological Transport; Brain; Dose-Response Relationship, Drug; Fluoxetine; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Wistar; Synaptosomes; Tritium; Vasoconstriction | 2006 |